filgotinib   Click here for help

GtoPdb Ligand ID: 7913

Synonyms: GLPG-0634 | GLPG0634 | Jyseleca®
Approved drug PDB Ligand Immunopharmacology Ligand
filgotinib is an approved drug (EMA (2020))
Compound class: Synthetic organic
Comment: Filgotinib is a selective and orally acive JAK1 inhibitor [3]. It is being developed in a collaboration between Gilead Sciences and Galapagos for the treatment of inflammatory indications including psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and rheumatoid arthritis. It is proposed as a once daily drug, that is predicted to cause fewer toxicity issues and adverse effects than existing JAK1 inhibitors.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 105.05
Molecular weight 425.15
XLogP 1.99
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES O=C(C1CC1)Nc1nc2n(n1)c(ccc2)c1ccc(cc1)CN1CCS(=O)(=O)CC1
Isomeric SMILES O=C(C1CC1)Nc1nc2n(n1)c(ccc2)c1ccc(cc1)CN1CCS(=O)(=O)CC1
InChI InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Janus kinase 1 Primary target of this compound Hs Inhibitor Inhibition 6.4 – 8.0 pIC50 - 1,3
pIC50 8.0 (IC50 1x10-8 M) [3]
pIC50 6.4 (IC50 3.63x10-7 M) [1]
Janus kinase 2 Hs Inhibitor Inhibition 5.6 – 7.5 pIC50 - 1,3
pIC50 7.5 (IC50 2.8x10-8 M) [3]
pIC50 5.6 (IC50 2.4x10-6 M) [1]
Janus kinase 3 Hs Inhibitor Inhibition 6.5 pIC50 - 3
pIC50 6.5 (IC50 8.1x10-7 M) [3]
tyrosine kinase 2 Hs Inhibitor Inhibition 5.6 – 6.9 pIC50 - 1,3
pIC50 6.9 (IC50 1.16x10-7 M) [3]
pIC50 5.6 (IC50 2.6x10-6 M) [1]